anti-t-cell antibodies
Biologicalexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2000 (NCT00190502)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- T-lymphocytesImmunity, passive
T-lymphocytes immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- anti-t-cell antibodies
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03357159 | Phase 2 | Sep 6, 2018 | Tel Aviv University |
| NCT00190502 | N/A | Nov 1, 2000 | Charles University, Government of Czech Republic |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Charles University | Academic/Hospital | 1 | 1 | 1 | 2000 |
| Government of Czech Republic | Government | 1 | 0 | 1 | 2000 |
| Tel Aviv University | Academic/Hospital | 1 | 1 | 1 | 2018 |
3 organizations
Page 1 / 1